genentech up $11 billion, page-5

Form my dicussions with Solbec, they have indicated that they know they have an "orphan druggable" drug but the focus of the phase II trials will be on cancers that exhibit the strongest reaction to Coramsine. Rational Theraputics in the US is conducting a study to determine which cancers exhibit the strongest reaction. These findings will be used to guide the selection of patients for the phase II trials.